After Hours Summary: SQ +15%, HLF +1.8%, RIG +1.4%, AGO +1.2% higher following earnings/guidance... TDOC -25.2%, HOS -7.9%, TRIP -7.3%, CF -4.8% on earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: SQ +14.8%, XPO +10.6%, AXGN +10%, PODD +8.6%, NSTG +8.3%, EPE +8%, JACK +7.7%, AVID +7.6%, GDDY +7.4% (also names new CFO), EXEL +7%, ERII +6.1%, SNCR +5.9%, MX +5.9%, ALIM +5%, FIVN +4.5%, CSII +3.9%, NLST +3.3%, SAND +3.1%, HIVE +3%, SXL +2.8%, TROX +2.6%, EVC +2.4%, CNAT +2.1%, LPI +1.9%, HLF +1.8%, RIG +1.4%, AGO +1.2%, OAS +1.2%, ETE +1%
Companies trading higher in after hours in reaction to news: OCUL +23.8% (updates on its NDA for DEXTENZA; FDA issued a letter noting that corrective actions detailed in its responses as a whole appear to address the ten inspectional observations raised), WMB +0.3% (Corvex Management discloses 4.1% active stake (Distributed ~10.8 mln shares to an investor in a co-investment Corvex Fund that holds only Shares of WMB), calls shares undervalued)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: TDOC -25.2%, SGMO -18.6%, TEGP -14.7%, FRSH -14.3%, BBRG -13.9%, INOV -13.9%, BSQR -13.3%, QUIK -11%, NSYS -9.7%, HOS -7.9%, TRIP -7.3%, UHAL -7.1%, FRGI -6.7%, SYNC -5.9%, GI -4.8%, (also files for $100 mln mixed securities shelf offering and 6,060,444 shares common stock offering by selling stockholders; announces recent FDA clearance and US launch of Lumos with Adaptive Matrix Imaging), CF -4.8%, PMT -4.7%, IRG -4.3%, MET -4.1%, LGCY -4%, XOMA -3.9%, GPOR -3.2%, CBPX -3.2%, (also expands share repurchase program to $100 mln from $50 mln), LNC -3%, DYN -3%, ALB -3%, MED -2.9%, ADRO -2.6%, PRU -2.5%, (also authorized a $500 mln increase to the existing share repurchase authorization for calendar year 2016), G -2.1%, EVHC -1.9%, BLUE -1.8%, TS -1.8%, CTL -1.7%, ANDE -1.3%, NLY -1%,
Companies trading lower in after hours in reaction to news: PQ -9.5% (in 10-Q adds a potential bankruptcy filing to list of risk factors - Was not part of 10-Q filed in May), ADAP -4.3% (received notice from the FDA that a partial clinical hold has been placed on its planned pivotal study of NY-ESO SPEAR T-cell therapy in myxoid round cell liposarcoma ), RYAM -4% (announces public offering of 1,250,000 shares of the Company's Series A Mandatory Convertible Preferred Stock ), TOPS -3.1% (enters into a senior secured facility with a major northern European bank for the financing of the M/T Nord Valiant), CP -2.2% (Canadian Pacific confirms the commencement of a public offering of 9,840,890 of common shares by certain funds managed by Pershing Square ), EXPE -0.5% (following TRIP earnings), VIPS -0.4% (Sequoia Capital lowers active stake to 4.6%)